{"denomUnitsSelected":"Participants","description":"Patient-reported neurotoxicity will be measured with FACT/GOG-Ntx subscale (short form).","reportingStatus":"NOT_POSTED","timeFrame":"0-54 weeks from start of treatment","title":"Incidence of Pembrolizumab Treatment and Self-reported Neurotoxicity","type":"OTHER_PRE_SPECIFIED"}